blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3103046

EP3103046 - BIOMARKER SIGNATURE METHOD, AND APPARATUS AND KITS THEREFOR [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.02.2021
Database last updated on 13.07.2024
FormerThe patent has been granted
Status updated on  21.02.2020
FormerGrant of patent is intended
Status updated on  18.08.2019
FormerExamination is in progress
Status updated on  15.07.2019
FormerGrant of patent is intended
Status updated on  20.01.2019
FormerExamination is in progress
Status updated on  13.07.2018
FormerRequest for examination was made
Status updated on  11.11.2016
Most recent event   Tooltip27.04.2024Lapse of the patent in a contracting state
New state(s): MK
published on 29.05.2024  [2024/22]
Applicant(s)For all designated states
Immunexpress Pty Ltd
6 Leonard Street
Boonah, Queensland 4310 / AU
[2016/50]
Inventor(s)01 / BRANDON, Richard Bruce
6 Leonard Street
Boonah, Queensland 4310 / AU
02 / MCHUGH, Leo Charles
112 10th Avenue East
Seattle, Washington 98122 / US
 [2016/50]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[2016/50]
Application number, filing date15746053.606.02.2015
[2016/50]
WO2015AU50043
Priority number, dateAU2014090036306.02.2014         Original published format: AU 2014900363
[2016/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015117204
Date:13.08.2015
Language:EN
[2015/32]
Type: A1 Application with search report 
No.:EP3103046
Date:14.12.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 13.08.2015 takes the place of the publication of the European patent application.
[2016/50]
Type: B1 Patent specification 
No.:EP3103046
Date:25.03.2020
Language:EN
[2020/13]
Search report(s)International search report - published on:AU13.08.2015
(Supplementary) European search report - dispatched on:EP25.07.2017
ClassificationIPC:G16B25/10, C12Q1/68, G01N33/50
[2019/07]
CPC:
C12Q1/6883 (EP,US); A61P31/04 (EP); A61P43/00 (EP);
G16B25/00 (EP,US); G16B25/10 (EP,US); G16B25/20 (EP,US);
G16B40/00 (EP,US); C12Q2600/118 (US); C12Q2600/16 (US) (-)
Former IPC [2016/50]G06F19/18, C12Q1/68, G01N33/50
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/50]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:BIOMARKERSIGNATURVERFAHREN SOWIE VORRICHTUNG UND KITS DAFÜR[2016/50]
English:BIOMARKER SIGNATURE METHOD, AND APPARATUS AND KITS THEREFOR[2016/50]
French:PROCÉDÉ DE SIGNATURE DE BIOMARQUEURS, ET APPAREIL ET KITS ASSOCIÉS[2016/50]
Entry into regional phase03.09.2016National basic fee paid 
03.09.2016Search fee paid 
03.09.2016Designation fee(s) paid 
03.09.2016Examination fee paid 
Examination procedure07.12.2015Request for preliminary examination filed
International Preliminary Examining Authority: AU
03.08.2016Date on which the examining division has become responsible
03.09.2016Examination requested  [2016/50]
13.02.2018Amendment by applicant (claims and/or description)
12.07.2018Despatch of a communication from the examining division (Time limit: M04)
16.11.2018Reply to a communication from the examining division
21.01.2019Communication of intention to grant the patent
31.05.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
31.05.2019Fee for grant paid
31.05.2019Fee for publishing/printing paid
19.08.2019Communication of intention to grant the patent
16.12.2019Receipt of the translation of the claim(s)
Opposition(s)12.01.2021No opposition filed within time limit [2021/11]
Fees paidRenewal fee
10.02.2017Renewal fee patent year 03
14.02.2018Renewal fee patent year 04
13.02.2019Renewal fee patent year 05
13.02.2020Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU06.02.2015
AT25.03.2020
CY25.03.2020
CZ25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
MK25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
[2024/22]
Former [2023/30]HU06.02.2015
AT25.03.2020
CY25.03.2020
CZ25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2023/27]HU06.02.2015
AT25.03.2020
CZ25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/41]AT25.03.2020
CZ25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
MC25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/24]AT25.03.2020
CZ25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SI25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/10]AT25.03.2020
CZ25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
PL25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2021/09]AT25.03.2020
CZ25.03.2020
EE25.03.2020
ES25.03.2020
FI25.03.2020
HR25.03.2020
IT25.03.2020
LT25.03.2020
LV25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2020/50]CZ25.03.2020
EE25.03.2020
FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2020/49]CZ25.03.2020
FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SK25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2020/48]FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
RO25.03.2020
RS25.03.2020
SE25.03.2020
SM25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
PT18.08.2020
Former [2020/47]FI25.03.2020
HR25.03.2020
LT25.03.2020
LV25.03.2020
RS25.03.2020
SE25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
Former [2020/46]FI25.03.2020
HR25.03.2020
LV25.03.2020
RS25.03.2020
SE25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
IS25.07.2020
Former [2020/39]FI25.03.2020
HR25.03.2020
LV25.03.2020
RS25.03.2020
SE25.03.2020
BG25.06.2020
NO25.06.2020
GR26.06.2020
Former [2020/38]FI25.03.2020
HR25.03.2020
LV25.03.2020
RS25.03.2020
SE25.03.2020
NO25.06.2020
GR26.06.2020
Former [2020/37]FI25.03.2020
HR25.03.2020
LV25.03.2020
RS25.03.2020
SE25.03.2020
NO25.06.2020
Former [2020/35]FI25.03.2020
NO25.06.2020
Documents cited:Search[A]US2004097460  (IVEY RICHARD M [US], et al) [A] 1-15;
 [A]US2004096917  (IVEY RICHARD M [US], et al) [A] 1-15;
 [X]WO2009045443  (UNIV ROCHESTER [US], et al) [X] 12-15 * the whole document, in particular claims *;
 [A]US2011312521  (CHAUSSABEL DAMIEN [US])[A] 1-15;
 [X]US2012082659  (LAND HARTMUT [US], et al) [X] 12-15 * the whole document, in particular paragraphs [0098], [0110] , [0248] and Tables 1, 8 *;
 [A]WO2012068642  (IMMUNEXPRESS PTY LTD [AU], et al) [A] 1-15;
 [T]  - LEO MCHUGH ET AL, "A Molecular Host Response Assay to Discriminate Between Sepsis and Infection- Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts", PLOS MEDICINE, (20151208), vol. 12, no. 12, doi:10.1371/journal.pmed.1001916, page e1001916, XP055336105

DOI:   http://dx.doi.org/10.1371/journal.pmed.1001916
 [A]  - MEARELLI FILIPPO ET AL, "Heterogeneous models for an early discrimination between sepsis and non-infective SIRS in medical ward patients: a pilot study", INTERNAL AND EMERGENCY MEDICINE, SPRINGER MILAN, MILAN, vol. 9, no. 7, doi:10.1007/S11739-013-1031-X, ISSN 1828-0447, (20131222), pages 749 - 757, (20131222), XP035401488 [A] 1-15

DOI:   http://dx.doi.org/10.1007/s11739-013-1031-x
 [A]  - ALLISON SUTHERLAND ET AL, "Development and validation of a novel molecular biomarker diagnostic test for the early detection of sepsis", CRITICAL CARE, BIOMED CENTRAL LTD., LONDON, GB, (20110620), vol. 15, no. 3, doi:10.1186/CC10274, ISSN 1364-8535, page R149, XP021106527 [A] 1-15

DOI:   http://dx.doi.org/10.1186/cc10274
 [A]  - YUQIAN MA ET AL, "Genome-Wide Sequencing of Cellular microRNAs Identifies a Combinatorial Expression Signature Diagnostic of Sepsis", PLOS ONE, (20131016), vol. 8, no. 10, doi:10.1371/journal.pone.0075918, page e75918, XP055390796 [A] 1-15

DOI:   http://dx.doi.org/10.1371/journal.pone.0075918
 [A]  - STEVEN B. JOHNSON ET AL, "Gene Expression Profiles Differentiate Between Sterile SIRS and Early Sepsis", ANNALS OF SURGERY, (20070401), vol. 245, no. 4, doi:10.1097/01.sla.0000251619.10648.32, ISSN 0003-4932, pages 611 - 621, XP055108540 [A] 1-15

DOI:   http://dx.doi.org/10.1097/01.sla.0000251619.10648.32
 [A]  - MICHAEL SCHLAME ET AL, "STUDY OF PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE IN THE PERIOPERATIVE PERIOD OF PATIENTS UNDERGOING CARDIAC SURGERY", SHOCK, (19980101), vol. 9, no. 5, doi:10.1097/00024382-199805000-00001, pages 313 - 319, XP055336808 [A] 1-15

DOI:   http://dx.doi.org/10.1097/00024382-199805000-00001
International search[X]WO9945398  (ARCTIC PARTNERS OY AB [FI], et al) [X] 1, 4-18, 24-30, 40, 101-107, 109-128, 134, 145 * page 5 line 24-page 6 line 10; page 16 lines 10-34; page 18 lines 18-31 *;
 [X]US2003219760  (GORDON GAVIN J [US], et al) [X] 1-24, 30, 40* [0066]-[0069], [0146], [0245], [0249], [0283], [0284], [0294] *;
 [X]WO2007060647  (TRINITY COLLEGE DUBLIN [IE], et al) [X] 1-30, 40, 101-134, 145 * Abstract; page 2 lines 11-18; page 6 lines 4-26; page 7 lines 25 - 29; page 18 lines 9-15; page 23 lines 20 - page 25 line 13; pages 48-54; claim 28 *;
 [X]WO2010083252  (US HEALTH [US], et al) [X] 1-18, 24-30, 40, 101-117, 134, 145 * page 74 lines 12-15; pages 78-87 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.